Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance
Provided By GlobeNewswire
Last update: Nov 6, 2025
-- Third quarter revenues up 6% driven by EXPAREL volume growth of 9% --
-- Several key milestones advance 5x30 path to growth and value creation --
Read more at globenewswire.com
